Patents by Inventor Gun-Do Kim

Gun-Do Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES COMPRISING VERATRIC ACID AS EFFECTIVE COMPONENT
    Publication number: 20140100286
    Abstract: There is provided a composition including a veratric acid for preventing or treating inflammatory diseases. The veratric acid of the present invention has an excellent effect of inhibiting production of nitric oxide, an excellent activity of inhibiting production of IL-1? as a pro-inflammatory cytokine, and an excellent effect of inhibiting phosphorylation of MAPK, NF-?B, GSK-3?, and c-Raf in a macrophage cell stimulated by a stimulation factor that causes an inflammatory reaction. Thus, it can be used for development of medicines for treating inflammatory diseases which can be caused by excessive inflammatory reactions. Further, the veratric acid of the present invention does not induce toxicity to cells and is stable in the body. Thus, it can be used as a material of a health functional food capable of preventing or improving inflammatory diseases.
    Type: Application
    Filed: June 27, 2013
    Publication date: April 10, 2014
    Inventors: Gun-Do KIM, Gyun-Pyung SHIN, Woo-Suk CHOI, Sang-Yeol LEE, Woe-Yeon KIM, Nam-Gyu PARK
  • 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors
    Patent number: 8598173
    Abstract: The present invention relates to novel quioxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives of formula (1): and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quioxalin-piperazine compounds are also included.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: December 3, 2013
    Assignees: Korea Research Institute of Chemical Technology, Rexahn Pharmaceuticals, Inc.
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Y. Kong, Gun-Do Kim, Chang Ho Ahn, Young Bok Lee
  • 1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
    Patent number: 8314100
    Abstract: The present invention related to a novel urea derivative for formula (I): which is useful as an anti-cancer agent, its pharmaceutically acceptable acid addition salt or stereoisomer, and to a process for preparing the urea derivative and an anti-cancer composition comprising the same as an active ingredient.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: November 20, 2012
    Assignees: Rexahn Pharmaceuticals, Inc., Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Yang Kong, Gun-Do Kim, Chang-Ho Ahn, Young Bok Lee
  • 1-[6,7-Substituted Alkoxyquinoxalinyl) Aminocarbonyl]-4-(Hetero) Arylpiperazine Derivatives
    Publication number: 20080318963
    Abstract: The present invention relates to novel quinoxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quinoxalin-piperazine compounds are also included.
    Type: Application
    Filed: October 18, 2005
    Publication date: December 25, 2008
    Applicants: REXAHN PHARMACEUTICALS, INC., KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Yang Kong, Gun-Do Kim, Chang-Ho Ahn, Young Bok Lee